Another Covid vaccine to go into phase 2/3 trial in Asia, Latin America, US. It's UB-612, peptide-based vaccine that's hoped to help prevent infection. https://clinicaltrials.gov/ct2/show/NCT04683224 Deal to produce for India & UNICEF https://covaxx.reportablenews.com/pr/covaxx-and-aurobindo-pharma-announce-covid-19-vaccine-partnership Records for this vax https://www.zotero.org/groups/2528572/covid-19_vaccine_results/tags/UB-612%20United%20Biomedical%2FCOVAXX/library

Press release for phase 1 results for UB-612 Covid vaccine (COVAXX). See : important peptide-based* vaccine, UNICEF support, hoped to prevent infection (*targets more than the spike protein). Reportedly low adverse events but not enough data on that.../ https://www.businesswire.com/news/home/20210208005198/en/COVAXX%E2%80%99s-COVID-19-Vaccine-UB-612-Induced-Neutralizing-Antibodies-in-100-of-Participants-During-Phase-1-Clinical-Trial

...Phase 2/3 trial to start in India soon - this could be a critical vaccine for LMICs (doesn't need super cold chain). Here's company's fact sheet about the vaccine: https://www.covaxx.com/vaccine  Other records for this vaccine: https://www.zotero.org/groups/2528572/covid-19_vaccine_results/tags/UB-612%20United%20Biomedical%2FCOVAXX/library